Designing Next-Generation iPSC-Based Cell Therapies by Rigorous Cellular and Genomic Characterization of iPSCs
9:30 am - Thursday 10th September 2026
- Presenting novel transgene modification, genomic location and promoter selection techniques to achieve sustained, tunable gene expression in iPSCs and their differentiated derivatives
- Leveraging whole genome sequencing and advanced bioinformatics pipelines to monitor genomic stability, distinguish inherited versus acquired variants, and ensure regulatory compliance
- Integrating multi‑omics data and rigorous QC processes to support the development and manufacturing of safe, consistent, and clinically viable iPSC‑based therapies
